Bullish
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
PepGen Inc. reported its first quarter 2026 financial results, highlighting encouraging progress in its FREEDOM2-DM1 trial for Myotonic Dystrophy Type...